Results of Individual Patient Dosimetry in Peptide Receptor Radionuclide Therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC-Reference-Cited by-同舟云学术

Results of Individual Patient Dosimetry in Peptide Receptor Radionuclide Therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC

Published:2007-06 Issue:3 Volume:22 Page:406-416
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Wehrmann Christiane¹,Senftleben Stefan¹,Zachert Carolin¹,Müller Dirk¹,Baum Richard P.¹

Affiliation:

1. Department of Nuclear Medicine/Center for P.E.T., Zentralklinik Bad Berka, Bad Berka, Germany

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/cbr.2006.325

Reference24 articles.

1. Imaging of Neuroendocrine Tumors

2. Yttrium-90-labelled somatostatin-analogue for cancer treatment

3. Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings

Cited by 169 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Removal of 177Lu from radioactive wastewater using Montmorillonite clay;Applied Radiation and Isotopes;2024-09

2. A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?;EJNMMI Physics;2024-07-18

3. Dosimetry: Was and Is an Absolute Requirement for Quality Radiation Research;Radiation Research;2024-07-02

4. Radioteragnosis en paragangliomas y feocromocitomas;Revista Española de Medicina Nuclear e Imagen Molecular;2024-07

5. Optimization of the number of post-therapeutic planar imaging time points for the most reliable organ and tumour dosimetry in peptide receptor radionuclide therapy;Health and Technology;2024-05-01